Abbvie Inc. (ABBV)

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Industry: Pharmaceutical Preparations (SIC 2834)

Market region: US

Address: 1 North Waukegan Road, North Chicago, IL, 60064

Market capitalization

521.11 billion USD (521,105,216,174 USD)

Listing date

12/10/2012

Weighted shares outstanding

1,767,117,285

Share class shares outstanding

1,766,792,821

https://www.abbvie.com